2022CSCO：殷永梅教授：HER-2阳性乳腺癌诊疗指南3大更新要点

2022-04-23 杭州市肿瘤医院倪丽伟 MedSci原创

最新HER-2阳性乳腺癌指南！看看指南怎么说。

乳腺癌是严重威胁全世界女性健康的第一大恶性肿瘤，乳腺癌患者中约80%为HR阳性。

4月23日，备受瞩目的2022CSCO指南大会隆重开幕。来自全国各肿瘤领域的专家和学者云端齐聚，开启了对紧跟前沿肿瘤研究和中国临床诊疗现状的CSCO系列指南的权威更新发布、解读和研讨之旅，共同推动肿瘤规范化诊疗。根据疫情防控要求，本次会议改为线上形式举办。

新版指南基于循证医学证据，兼顾诊疗产品的可及性，为中国乳腺癌诊疗提供规范化诊疗意见。本文由江苏省人民医院殷咏梅教授详细讲解HER-2阳性乳腺癌诊疗指南中新辅助治疗、辅助治疗以及HER-2阳性复发转移性乳腺癌治疗的更新要点。

1、HER-2阳性乳腺癌新辅助治疗

2、HER-2阳性乳腺癌辅助治疗

3、HER-2阳性复发转移性乳腺癌治疗

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言

评论区 (4)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1218229, encodeId=78d5121822905, content=<a href='/topic/show?id=70221045206d' target=_blank style='color:#2F92EE;'>#殷永梅#</a>教授：<a href='/topic/show?id=01ee104521ac' target=_blank style='color:#2F92EE;'>#HER-2阳性乳腺癌#</a><a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104520, encryptionId=70221045206d, topicName=殷永梅), TopicDto(id=104521, encryptionId=01ee104521ac, topicName=HER-2阳性乳腺癌), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 17:07:10 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495811, encodeId=dabc149581149, content=<a href='/topic/show?id=27eb8e1381' target=_blank style='color:#2F92EE;'>#HER-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8713, encryptionId=27eb8e1381, topicName=HER-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b8b9208832, createdName=zhu_jun9840, createdTime=Mon Apr 25 11:40:06 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213785, encodeId=49381213e859f, content=好用<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fdb6533655, createdName=ms7000001105543453, createdTime=Sat Apr 23 23:46:18 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
2022-05-09 病毒猎手

#殷永梅#教授：#HER-2阳性乳腺癌##乳腺癌#

178 0
[GetPortalCommentsPageByObjectIdResponse(id=1218229, encodeId=78d5121822905, content=<a href='/topic/show?id=70221045206d' target=_blank style='color:#2F92EE;'>#殷永梅#</a>教授：<a href='/topic/show?id=01ee104521ac' target=_blank style='color:#2F92EE;'>#HER-2阳性乳腺癌#</a><a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104520, encryptionId=70221045206d, topicName=殷永梅), TopicDto(id=104521, encryptionId=01ee104521ac, topicName=HER-2阳性乳腺癌), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 17:07:10 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495811, encodeId=dabc149581149, content=<a href='/topic/show?id=27eb8e1381' target=_blank style='color:#2F92EE;'>#HER-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8713, encryptionId=27eb8e1381, topicName=HER-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b8b9208832, createdName=zhu_jun9840, createdTime=Mon Apr 25 11:40:06 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213785, encodeId=49381213e859f, content=好用<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fdb6533655, createdName=ms7000001105543453, createdTime=Sat Apr 23 23:46:18 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
2022-04-25 zhu_jun9840

#HER-2#

98 0
[GetPortalCommentsPageByObjectIdResponse(id=1218229, encodeId=78d5121822905, content=<a href='/topic/show?id=70221045206d' target=_blank style='color:#2F92EE;'>#殷永梅#</a>教授：<a href='/topic/show?id=01ee104521ac' target=_blank style='color:#2F92EE;'>#HER-2阳性乳腺癌#</a><a href='/topic/show?id=73c423e2572' target=_blank style='color:#2F92EE;'>#乳腺癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=178, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104520, encryptionId=70221045206d, topicName=殷永梅), TopicDto(id=104521, encryptionId=01ee104521ac, topicName=HER-2阳性乳腺癌), TopicDto(id=23725, encryptionId=73c423e2572, topicName=乳腺癌)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Mon May 09 17:07:10 CST 2022, time=2022-05-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1495811, encodeId=dabc149581149, content=<a href='/topic/show?id=27eb8e1381' target=_blank style='color:#2F92EE;'>#HER-2#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8713, encryptionId=27eb8e1381, topicName=HER-2)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6b8b9208832, createdName=zhu_jun9840, createdTime=Mon Apr 25 11:40:06 CST 2022, time=2022-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213785, encodeId=49381213e859f, content=好用<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=184, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0fdb6533655, createdName=ms7000001105543453, createdTime=Sat Apr 23 23:46:18 CST 2022, time=2022-04-23, status=1, ipAttribution=)]
2022-04-23 ms7000001105543453

好用#学习#

184 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

肿瘤

2022CSCO：殷永梅教授：HER-2阳性乳腺癌诊疗指南3大更新要点

相关资讯

科室

工具

服务